-
1
المؤلفون: Anjali Bajaj, S Sreedevi, Shantaraman Kalyanaraman, Devarshi U. Gajjar, Kavita Pandhare, Nachimuthu Senthil Kumar, J Ezhil Ramya, Nikhil V. Palande, Sumit Sharma, Mohamed Imran, Rohit Yadav, Vigneshwar Senthivel, Mohit Mangla, Mohit Kumar Divakar, Sridhar Sivasubbu, Ranjan Jyoti Sarma, Lalchhandama Chhakchhuak, S. Jain, Disha Sharma, Ronibala Soraisham, Prashant Kumar Mishra, Sudip Kumar Sahana, Raskin Erusan Rajagopal, Mercy Rophina, Rahul C. Bhoyar, Anushree Mishra, Yumnam Silla Devi, Arun G. Jadhao, Sanjay Siwach, Aayush Gupta, B K Binukumar, Mitali Mukerji, Andrew Vanlallawma, Ganga Nath Jha, Nishat Ashrafi, A K Vidhya, Abhinav Jain, Samatha Mathew, Kandarp Joshi, Meya Kumla, Sivaprakash Ramalingam, Debasis Dash, Ambily Sivadas, Vishu Gupta, Sangam Goswami, Radha Mahadevan, Pabitha Devi, Vinod Scaria, Arushi Batra, Sunitha Kandasamy, P Nirmala Devi, Savinitha Prakash, Bani Jolly
المصدر: Pharmacogenomics
مصطلحات موضوعية: 0301 basic medicine, Drug, Indian population, Coronavirus disease 2019 (COVID-19), Genotype, Pharmacogenomic Variants, media_common.quotation_subject, India, Ethnic populations, Bioinformatics, drug–drug–gene interactions, Genome, Antiviral Agents, 03 medical and health sciences, 0302 clinical medicine, Asian People, Genetics, Medicine, Humans, In patient, Drug Interactions, media_common, Pharmacology, pharmacogenomics, business.industry, SARS-CoV-2, COVID-19, Pharmacogenomic Testing, COVID-19 Drug Treatment, 030104 developmental biology, Pharmacogenetics, 030220 oncology & carcinogenesis, Pharmacogenomics, Molecular Medicine, COVID-19 therapies, drug–drug interactions, business, Research Article